Skip to main content
. Author manuscript; available in PMC: 2013 Jan 18.
Published in final edited form as: Bioconjug Chem. 2012 Jan 4;23(1):57–65. doi: 10.1021/bc200330m

Table 5.

Antibacterial activity of avarone, its derivatives, lysozyme and its conjugates with various derivatives of avarone towards Gram-positive bacteria (in parentheses are the MIC of the conjugates expressed as quinone concentration)

MIC (μM)
Compound S. lutea S. aureus M. flavus S.
longisporum
C.
sporogenes
B.subtilis
I 20.03 40.06 20.03 20.03 20.03 80.13
Ia 36.55 36.55 36.55 36.55 18.27 36.55
Ib - - - - - -
Ic 469.21 3812.32 3812.32 3812.32 3812.32 967.74
I-L 168.23
(3.59)
5.47
(0.12)
168.23
(3.59)
168.23
(3.59)
336.46
(7.18)
168.23
(3.59)
Ia-L 95.54
(2.23)
3.07
(0.07)
191.09
(4.46)
191.09
(4.46)
191.09
(4.46)
191.09
(4.46)
Ib-L 102.38
(2.38)
1.71
(0.04)
402.68
(9.37)
204.75
(4.77)
204.75
(4.77)
204.75
(4.77)
Ic-L 95.55
(2.22)
1.54
(0.04)
395.85
(9.21)
197.92
(4.61)
197.92
(4.61)
197.92
(4.61)
Treated-L 223.57 27.94 111.79 447.15 223.57 111.79
Lysozyme 202.61 12.58 405.23 405.23 817.44 202.61
Amikacin 3.42 18.78 3.42 111.00 25.61 71.72